JACC: Cardiooncology

Article	Citations
Cardiac Tumors	191
Cardiovascular Effects of CAR T Cell Therapy	81
Cardiovascular Risk Factors Are Associated With Future Cancer	79
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification	78
Venous and Arterial Thromboembolism in Patients With Cancer	75
Cardiovascular Manifestations From Therapeutic Radiation	74
The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer	70
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity	68
Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis	64
ATTR Amyloidosis: Current and Emerging Management Strategies	62
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation	58
Incident Cardiovascular Disease Among Adults With Cancer	55
Risk of Atrial Fibrillation According to Cancer Type	54
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis	53
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity	52
Strain Imaging in Cardio-Oncology	52
Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors	47
Direct Oral Anticoagulants in Patients With Active Cancer	41
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury	39
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis	38
Cardiac Disease in Childhood Cancer Survivors	36
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors	33
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab	33
Electrophysiological Manifestations of Cardiac Amyloidosis	31
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies	31

Immune Checkpoint Inhibitor Therapy in Oncology	30
Arterial Thromboembolism in Cancer Patients	30
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment	29
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer	28
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer	28
Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity	28
Low QRS Voltages in Cardiac Amyloidosis	26
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population	26
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil–Associated Coronary Vasospasm	26
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis	24
AL Amyloidosis for Cardiologists	23
Cardiovascular Disease in Myeloproliferative Neoplasms	23
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy	23
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter	23
Two Decades of Cardiac Amyloidosis	23
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey	22
Racial and Ethnic Disparities in Cardio-Oncology	22
Atherosclerosis With Immune Checkpoint Inhibitor Therapy	22
Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort	21
Management of Immune Checkpoint Inhibitor–Induced Myocarditis	21
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States	21
Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States	20
Cardio-Oncology Care in the Time of COVID-19 and the Role of Telehealth	20
Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting	20
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?	20
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis	19
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients	18
Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer	18
Takotsubo Cardiomyopathy Associated With Checkpoint Inhibitor Therapy	18
A Proteomic Atlas of Cardiac Amyloid Plaques	17
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma	17
Cardiometabolic Comorbidities in Cancer Survivors	17
Role of Physical Activity and Cardiac Rehabilitation in Patients Undergoing Hematopoietic Stem Cell Transplantation	17
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors	16
How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain	16
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer	16
Immune Checkpoint Inhibitor-Associated Myocarditis With Persistent Troponin Elevation Despite Abatacept and Prolonged Immunosuppression	16
Risk of Cancer After Diagnosis of Cardiovascular Disease	16
Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors	16
How to Diagnose and Manage QT Prolongation in Cancer Patients	15
The Role of Healthy Lifestyle in Cancer Incidence and Temporal Transitions to Cardiometabolic Disease	15
Cardiac Computed Tomography in Cardio-Oncology	15
Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer	15
Oncotherapeutic Protein Kinase Inhibitors Associated With Pro-Arrhythmic Liability	15
Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy	15
Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors	15
Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors	14
Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer	14
Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy	14
Transcatheter Compared With Surgical Aortic Valve Replacement in Patients With Previous Chest-Directed Radiation Therapy	13

Primer on Biomarker Discovery in Cardio-Oncology	13
How to Manage Atrial Fibrillation Secondary to Ibrutinib	13
The TICONC (Ticagrelor-Oncology) Study	13
Contribution of Polygenic Risk to Hypertension Among Long-Term Survivors of Childhood Cancer	12
Screening for Coronary Artery Disease in Cancer Survivors	12
Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions	12
Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy	12
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations	12
Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors	12
Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness	12
Permissive Cardiotoxicity	12
How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk	12
Clonal Hematopoiesis and JAK2V617F Mutations in Patients With Cardiovascular Disease	11
The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer	11
Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies	11
Acute Heart Failure 29 Years After Treatment for Childhood Cancer	11
Cardiotoxicity of T-Cell Antineoplastic Therapies	11
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies	11
Prevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies	11
Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S.	11
Longitudinal Strain and Troponin I Elevation in Patients Undergoing Immune Checkpoint Inhibitor Therapy	11
Cardiac Magnetic Resonance for Early Detection of Radiation Therapy-Induced Cardiotoxicity in a Small Animal Model	10
Cardiac Biomarkers During Cancer Therapy	10
Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer Survivors at Risk for Cardiomyopathy	10
Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation	10
Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement	10
Computed Tomographic Angiography Assessment of Epicardial Coronary Vasoreactivity for Early Detection of Doxorubicin-Induced Cardiotoxicity	10
3-Year Follow-Up of Radiation-Associated Changes in Diastolic Function by Speckle Tracking Echocardiography	9
Self-Reported Physical Activity, QoL, Cardiac Function, and Cardiorespiratory Fitness in Women With HER2+ Breast Cancer	9
Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps	9
Modified Routine Cardiac Imaging Surveillance of Adult Cancer Patients and Survivors During the COVID-19 Pandemic	9
Association of Cardiometabolic Disease With Cancer in the Community	9
COVID-19 Clinical Trials	9
Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity	9
Cardiac Transplantation and Mechanical Circulatory Support in Amyloidosis	9
Clinical, Echocardiographic, and Biomarker Associations With Impaired Cardiorespiratory Fitness Early After HER2-Targeted Breast Cancer Therapy	9
Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation	9
Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials	8
Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors	8
Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats	8
Time-Restricted Eating to Reduce Cardiovascular Risk Among Older Breast Cancer Survivors	7
Arterial Thromboembolism in Patients With AF and CHA2DS2-VASc Score 0-2 With and Without Cancer	7
Uridine Triacetate for Severe Fluoropyrimidine Cardiotoxicity in a Patient With Thymidylate Synthase Gene Variants	7
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis	7
How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy	7
From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction	7
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism	7
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia	7
Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy	7
Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism	7
Financial Toxicity in Cancer and Cardiovascular Disease	7
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms	7
Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer	7
Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab	6
Healthy Lifestyle Benefits Both Cancer and Cardiovascular Disease	6
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation	6
Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation	6
Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease	6
Cardiac Magnetic Resonance in Cardio-Oncology	6
Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent	6
Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer	6
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo	6
Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer	5
Outcomes of Cancer Patients Undergoing Transcatheter Aortic Valve Replacement	5
Overcoming LGBTQI+ Disparities in Cardio-Oncology	5
Reversible Myocardial Edema Secondary to Tagraxofusp-Induced Capillary Leak Syndrome	5
Association of Midlife Cardiovascular Health and Subsequent Change in Cardiovascular Health With Incident Cancer	5
Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors	5
Cardiovascular Toxicity With Cisplatin in Patients With Testicular Cancer	5
Remote Ischemic Conditioning in Pediatric Cancer Patients Receiving Anthracycline Chemotherapy	5
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies	5
How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia	5
Considerations of Competing Risks Analysis in Cardio-Oncology Studies	5
Heart Transplantation in Adriamycin-Associated Cardiomyopathy in the Contemporary Era of Advanced Heart Failure Therapies	5
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies	5
Radiation-Associated Coronary Disease in Young Cancer Survivors	5
How to Diagnose and Manage Radiation Cardiotoxicity	5
Successful CAR T Cell Therapy in a Heart and Kidney Transplant Recipient With Refractory PTLD	5
Combat Doxorubicin Cardiotoxicity With the Power of Mitochondria Transfer	5
5-Fluorouracil Cardiotoxicity	5

Physician Knowledge and Awareness About Cardiac Amyloidosis in the Middle East and Gulf Region	5
Cardio-Oncology in Japan	5
Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance	5
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer	5
Validity of Estimated Cardiorespiratory Fitness in Patients With Primary Breast Cancer	5